Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Details Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

2006-07-11

2006-07-11

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S134000

Reexamination Certificate

active

07074788

ABSTRACT:
The present invention relates to compounds with the formula (I)and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-β-hydroxysteroid dehydrogenase type 1 enzyme.

REFERENCES:
patent: 3332942 (1967-07-01), Breivogel
patent: 5783597 (1998-07-01), Beers et al.
patent: 5962490 (1999-10-01), Chan et al.
patent: 2003/0130279 (2003-07-01), Kurz et al.
patent: 2003/0130318 (2003-07-01), Barf et al.
patent: 2003/0166689 (2003-09-01), Kurz et al.
patent: 2003/0176476 (2003-09-01), Barf et al.
patent: 2003/0199501 (2003-10-01), Nilsson et al.
patent: 0 749 964 (1996-12-01), None
patent: 0 790 057 (1997-08-01), None
patent: 2 384 498 (1978-10-01), None
patent: 822947 (1959-11-01), None
patent: 839316 (1960-06-01), None
patent: 858189 (1961-01-01), None
patent: 1053085 (1966-12-01), None
patent: 1240545 (1971-07-01), None
patent: WO 98/16520 (1998-04-01), None
patent: WO 98/27081 (1998-06-01), None
patent: WO 99/02502 (1999-01-01), None
patent: WO 01/54691 (2001-08-01), None
patent: WO 01/90090 (2001-11-01), None
patent: WO 0190091 (2001-11-01), None
patent: WO 03044000 (2003-05-01), None
Caplus, “2-Naphthalenesulfonamide, N-(5-(4-pyridinyl)-1,3,4-thiadiazol-2-yl)-,” Oak Samples Product List, (Oct. 8, 2001). Caplus Accession No. 2001:528398, Order No. CD212010, CAS Registry No. 326886-15-1.
Caplus, “Benzenesulfonamide, N-(5-(4-pyridinyl)-1,3,4-thiadiazol-2-y1)-,” Oak Samples Product List, (Oct. 8, 2001). Caplus Accession No. 2001:528397, Order No. CD212009, CAS Registry No. 326886-14-0.
Caplus, “Synthesis and antiviral activity of N-(p-(R-sulfamoyl)phenyl)succinamic acids and their 2-amino-2-thiazoline salts,” Khimiko-Farmatsevticheskii Zhurnal (1977), 31(9), 24-26, Caplus Accession No. 1998: 231998, Document No. 128:265804.
Caplus, “Penetration of sulfanilamides into inflammatory foci,” Khimiko-Farmatsevticheskii Zhurnal (1982), 16(6), 665-7. Caplus Accession No. 1982:484681, Document No. 97:84681.
Anton-Fos et al., “Pharmacological Studies of the Two New Hypoglycaemic Compounds 4-(3-Methyl-5-oxo-2-pyrazolin-1-hl)benzoic Acid and 1-(Mesitylen-2-sulfonyl)-1H-1,2,4-triazole,” Arzneim.-Forsch./Drug Res 44(11), No. 7, 1994, pp. 821-826.
Merck & Co. Inc., USA, 1999, Monograph No. 4488, “Glybuzole,” CAS Registry No. 1492-02-0.
Merck & Co. Inc., USA, 1999, Monograph No. 9084, “Sulfamethizole,” CAS Registry No. 144-82-1.
Stozowaka, W. et al., “Urinary silver an Sulfathiazole levels in thermally injured guinea pigs during treatment with silver sulfathiazole cream”, S.T.P. Pharma Sciences, vol. 5, No. 6, 1995, pp. 452-455.

Affiliated with

Also associated with

Rating

Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3549514